首頁市場股票ResMed Inc - US

交易 ResMed Inc - US - RMD 差價合約

271.89+0.16%
The chart shows the RMD stock price data over the last 1 day, with a current price of 271.89, a high of 271.65, and a low of 268.83.
低點: 268.83高點: 271.65
賣方:
0%
買方:
100%
過往表現並非未來業績的可靠指標
交易條件
類型
該金融市場可進行差價合約交易。
了解更多:差價合約
差價合約
點差0.54
長倉隔夜倉息調整
長倉隔夜倉息調整

保證金。您的投資
$1,000.00
隔夜倉息
來自頭寸全值的費用
-0.021568 %
(-$1.08)

使用杠杆的交易規模(大約值)$5,000.00

來自杠杆的資金 - 美元(大約值)$4,000.00


-0.02157%
短倉隔夜倉息調整
短倉隔夜倉息調整

保證金。您的投資
$1,000.00
隔夜倉息
來自頭寸全值的費用
-0.000654 %
(-$0.03)

使用杠杆的交易規模(大約值)$5,000.00

來自杠杆的資金 - 美元(大約值)$4,000.00


-0.00065%
隔夜倉息調整時間22:00 (UTC)
貨幣USD
最低成交量0.1
保證金20.00%
證券交易所United States of America
交易佣金10%
保證止損溢價
保證止損 (GSL) 費用僅在 GSL 被觸發時收取。更多詳情請參閱我們網站的「服務費用」 頁面。
1%

1我們執行交易收取的費用是點差,即買入價和賣出價之間的差額。有關更多資訊,請參閱我們網站上的收費頁面

主要統計數據
前收盤價266.81
開倉269.64
1 年變化26.77%
日區間268.83 - 271.65
ResMed (RMD) is a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD) and other chronic diseases. SDB includes obstructive sleep apnoea (OSA), and other respiratory disorders that occur during sleep. The company’s products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. ResMed’s cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes and efficiencies for their customers. ResMed employs about 5,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. The ResMed share price is available at Capital.com.

最新股票文章

阿里巴巴突破楔形整理
阿里巴巴突破楔形整理,AI 動能回溫帶動股價走勢
阿里巴巴(Alibaba)正逐漸成為 AI 領域中不可忽視的關鍵角色。
07:42, 14 1月 2026
特斯拉財報不及預期後的交易動向
特斯拉財報不及預期後的交易動向
第二季財報盈餘與營收皆未達預期,股價在盤後交易下跌,執行長馬斯克警告可能將面臨「幾個艱難的季度」
20:07, 24 7月 2025
寧德時代(CATL)股票預測
寧德時代(CATL)股票預測:第三方價格目標
探索寧德時代(CATL)2025年及未來的股價預測,涵蓋分析師目標價等關鍵訊息
13:25, 11 6月 2025